89 results
S-1
EX-10.17
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
) “Independent Counsel” shall mean a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor … to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include
DEF 14A
VERV
Verve Therapeutics Inc
29 Apr 22
Definitive proxy
7:01am
independent registered public accounting firm for the fiscal year ending December 31, 2022; and
3.Transaction of any other business properly brought … in Office
Executive Officers Who Are Not Directors
PROPOSAL NO. 2—RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Audit Committee Pre-Approval
8-K
VERV
Verve Therapeutics Inc
13 Jun 22
Departure of Directors or Certain Officers
4:34pm
been duly elected and qualified, or until his earlier death, resignation or removal. The Board has determined that Mr. Cumbo is “independent … .
Proposal 2 – Ratification of Appointment of the Company’s Independent Registered Public Accounting Firm
The stockholders of the Company ratified
8-K
xhntmva
16 Jun 23
Submission of Matters to a Vote of Security Holders
9:02am
8-K
EX-99.1
pn2vrl3t7bg5rk2
7 Nov 22
Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results
7:00am
CORRESP
fwmslw
28 May 21
Correspondence with SEC
12:00am
S-8
EX-23.1
z43kro6i3914jova
17 Jun 21
Registration of securities for employees
4:54pm
S-8
EX-23.2
habsokm9g
27 Feb 24
Registration of securities for employees
8:32am
S-1
EX-23.1
48ev62bn kfwb
28 May 21
IPO registration
4:04pm
8-K
lq8j0 6f23b
13 Nov 23
Other Events
6:34am
S-8
EX-23.1
wtn4zd9i v74zll4
14 Mar 22
Registration of securities for employees
7:20am
S-3
EX-23.1
q9tspzcajc 3vyx
1 Jul 22
Shelf registration
4:36pm
10-K
EX-23.1
rewo3gzvdsu87
14 Mar 22
Annual report
7:04am
8-K
EX-99.1
i11y8t16wtr0ftts33qx
10 Aug 23
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
7:00am
S-1/A
EX-23.1
kuopn
14 Jun 21
IPO registration (amended)
6:15am
S-3ASR
EX-23.1
iqozvaq5
23 Sep 22
Automatic shelf registration
4:08pm
S-1MEF
EX-23.1
u9w0g2m7chpn
16 Jun 21
Registration of additional securities for an S-1
6:57pm